The post hoc analysis was funded by Medtronic, and Dr. Lee is an employee of the company. Dr. Garber is a consultant/advisory board member and/or on the speakers bureaus for Novo Nordisk, Daiichi Sankyo, Merck, Takeda, LipoScience, Boehringer Ingelheim, Sekris, and Lexicon.
Conference Coverage
At 2 Years, Resolute Stent Performs Well in Diabetes Patients
Publish date: May 31, 2012
FROM THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS